Back

Trimethylamine-N-oxide (TMAO) is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Atrial fibrillation e-posters Stroke in Atrial Fibrillation ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Marco Luciani

University Hospital Zurich, Zurich (Switzerland)

160 More presentations in this session

Presentation thumbnail
The impact of abnormal conduction zone on outcomes after catheter ablation for atrial fibrillation
Associate Professor T. Mine (Nishinomiya, JP)
Abstract Slides
Presentation thumbnail
Thromboembolic risk of movable type left atrial appendage thrombi in patients with atrial fibrillation under widespread use of anticoagulants
Doctor M. Sugitani (Nishinomiya, JP)
Abstract Slides
Presentation thumbnail
Rate and rhythm control treatment in the elderly and very elderly patients with atrial fibrillation: an observational cohort study of 1,497 patients
Mr T. Klamer (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices
Doctor M. Mansour (Beirut, LB)
Abstract Slides
Presentation thumbnail
Risk prediction of atrial fibrillation and its complications in the community using high-sensitivity cardiac Troponin I: Results from the BiomarCaRE Consortium
Doctor C. Boerschel (Hamburg, DE)
Abstract Slides

Access the full session

Session thumbnail
Atrial fibrillation e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources